Thermo Fisher Scientific Inc. (TN8.DE)
EUR 505.8
(0.08%)
EUR 505.8
(0.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 42.85 Billion | 41.96 Billion | 34.49 Billion | 26.33 Billion | 22.75 Billion | 21.3 Billion |
| Cost of Revenue | 27.63 Billion | 24.2 Billion | 17.22 Billion | 13.23 Billion | 12.64 Billion | 11.69 Billion |
| Gross Profit | 15.22 Billion | 17.76 Billion | 17.27 Billion | 13.09 Billion | 10.1 Billion | 9.61 Billion |
| Operating Expenses | 22.83 Billion | 9.79 Billion | 8.19 Billion | 6.64 Billion | 6.31 Billion | 6.22 Billion |
| Selling, General and Administrative Expenses | 8.38 Billion | 8.42 Billion | 6.95 Billion | 5.67 Billion | 5.4 Billion | 5.27 Billion |
| Research and Development Expenses | 1.33 Billion | 1.37 Billion | 1.23 Billion | 965.22 Million | 893.54 Million | 845.9 Million |
| Other Expenses | 13.04 Billion | -104 Million | -694 Million | -76 Million | -17.81 Million | -105.84 Million |
| Cost and Expenses | 35.99 Billion | 34 Billion | 25.41 Billion | 19.87 Billion | 18.96 Billion | 17.92 Billion |
| Operating Income | 6.85 Billion | 7.96 Billion | 9.07 Billion | 6.45 Billion | 3.79 Billion | 3.38 Billion |
| Interest Expense | 1.37 Billion | 726 Million | 536 Million | 553 Million | 602.22 Million | 583.47 Million |
| Income Tax Expense | 284 Million | 656.85 Million | 975.68 Million | 694.69 Million | 333.18 Million | 283.42 Million |
| Earnings before Tax | 6.29 Billion | 7.32 Billion | 7.77 Billion | 5.9 Billion | 3.62 Billion | 2.85 Billion |
| Net Income | 5.99 Billion | 6.95 Billion | 7.72 Billion | 6.37 Billion | 3.29 Billion | 2.57 Billion |
| Earnings Per Share Basic | 15.53 | 16.57 | 17.25 | 13.16 | 8.23 | 6.39 |
| Earnings Per Share Diluted | 15.45 | 16.48 | 17.12 | 13.06 | 8.17 | 6.33 |
| Weighted Average Shares Outstanding | 386 Million | 392 Million | 394 Million | 396 Million | 400 Million | 402 Million |
| Weighted Average Shares Outstanding (Diluted) | 388 Million | 394 Million | 397 Million | 399 Million | 403 Million | 406 Million |
| Gross Margin | 0.36 | 0.42 | 0.50 | 0.50 | 0.44 | 0.45 |
| EBIT Margin | 0.25 | 0.27 | 0.33 | 0.32 | 0.26 | 0.25 |
| Profit Margin | 0.14 | 0.17 | 0.22 | 0.24 | 0.14 | 0.12 |
| EBITDA | 10.8 Billion | 11.12 Billion | 11.96 Billion | 10.1 Billion | 5.82 Billion | 5.36 Billion |
| Earnings Before Tax Margin | 0.16 | 0.19 | 0.26 | 0.25 | 0.17 | 0.16 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 10.54 Billion | 9.58 Billion | 9.86 Billion | 38.82 Billion | 10 Billion | 9.79 Billion |
| Cost of Revenue | 6.19 Billion | 5.67 Billion | 6.27 Billion | 23.25 Billion | 5.9 Billion | 5.88 Billion |
| Gross Profit | 4.34 Billion | 3.9 Billion | 3.58 Billion | 15.57 Billion | 4.09 Billion | 3.91 Billion |
| Operating Expenses | 2.45 Billion | 2.31 Billion | 1.77 Billion | 8.83 Billion | 2.23 Billion | 2.28 Billion |
| Selling, General and Administrative Expenses | 2.11 Billion | 2 Billion | 1.48 Billion | - | 1.92 Billion | 1.96 Billion |
| Research and Development Expenses | 339 Million | 306.76 Million | 296.26 Million | - | 301.77 Million | 316.29 Million |
| Other Expenses | 5 Million | 10 Million | -33 Million | -65 Million | 14 Million | - |
| Cost and Expenses | 8.64 Billion | 7.99 Billion | 8.05 Billion | 32.08 Billion | 8.13 Billion | 8.16 Billion |
| Operating Income | 1.82 Billion | 1.59 Billion | 1.8 Billion | 6.74 Billion | 1.86 Billion | 1.63 Billion |
| Interest Expense | 354 Million | 363 Million | 390 Million | 1.37 Billion | 359 Million | 326 Million |
| Income Tax Expense | 128 Million | 260.42 Million | 120.49 Million | 257.3 Million | 50.13 Million | 47.67 Million |
| Earnings before Tax | 1.76 Billion | 1.47 Billion | 1.57 Billion | 5.7 Billion | 1.66 Billion | 1.31 Billion |
| Net Income | 1.54 Billion | 1.32 Billion | 1.63 Billion | 5.99 Billion | 1.71 Billion | 1.36 Billion |
| Earnings Per Share Basic | 3.78 | 3.22 | 3.82 | - | 4.20 | 3.23 |
| Earnings Per Share Diluted | 3.77 | 3.21 | 3.81 | - | 4.18 | 3.22 |
| Weighted Average Shares Outstanding | 382 Million | 382 Million | 387 Million | 386 Million | 386 Million | 386 Million |
| Weighted Average Shares Outstanding (Diluted) | 383 Million | 384 Million | 388 Million | 388 Million | 388 Million | 388 Million |
| Gross Margin | 0.41 | 0.41 | 0.36 | 0.40 | 0.41 | 0.40 |
| EBIT Margin | 0.28 | 0.25 | 0.26 | - | 0.27 | 0.25 |
| Profit Margin | 0.15 | 0.14 | 0.17 | 0.15 | 0.17 | 0.14 |
| EBITDA | 2.98 Billion | 2.36 Billion | 2.56 Billion | - | 2.67 Billion | 2.41 Billion |
| Earnings Before Tax Margin | 0.17 | 0.17 | 0.18 | 0.17 | 0.19 | 0.17 |
002545
300188
002599
000852
SIXD
ARCH